ALNY vs SAIA · P/E 76, rev $1.29B vs P/E 45, rev $1.76B
Alnylam Pharmaceuticals Inc (ALNY) versus Saia Inc (SAIA) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Saia Inc (SAIA) is a trucking company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported SAIA revenue for 2026-06-30 was $1.76B. Net income was $144.1M. SAIA currently screens at market cap $11.33B and trailing P/E 44.8.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. SAIA currently screens at market cap $11.33B and trailing P/E 44.8.
Not investment advice. Open the ALNY and SAIA stock pages for the full models.
Not investment advice.